In Mississippi, Medicaid Coverage of Weight Loss Drugs Fails To Catch On
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
The independent source for health policy research, polling, and news.
161 - 180 of 3,879 Results
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
Environmental and economic concerns prompt some people to explore obsequies options beyond metal caskets and cremation.
KFF Health News journalists made the rounds on national media recently to discuss topical stories. Here’s a collection of their appearances.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
As contractors position themselves to cash in on a gush of new business managing Medicaid work requirements, a cadre of senators has launched an inquiry into the companies paid billions to build eligibility systems.
Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress — a potential tool for those with high trauma rates, like firefighters and police officers. Yet the drug’s stigma and unregulated marketplace leave first responders in uncharted territory.
On the "Today, Explained" podcast, KFF Health News' Julie Rovner recaps the TrumpRx announcement and why the direct-to-consumer initiative may not save you money on prescription drugs if you have insurance through your employer or the government.
California’s nursing shortage is projected to worsen, and hospitals say funding cuts will only add strain. But front-line nurses blame heavy workloads, not a shortage, for driving workers away.
The Trump administration has restored promised funds to a program that teaches people in health care how to work with aging Americans.
Amid concerns that Health and Human Services Secretary Robert F. Kennedy Jr. is undermining trust in vaccines and public health science, some states are seeking new sources of scientific consensus and changing how they regulate insurance companies, prescribers, and pharmacists. Colorado has been at the front of this wave.
The evidence is unequivocal: Vaccines do not cause autism. Yet adding autism to the list of conditions covered by a federal payout program, as health secretary Robert F. Kennedy Jr. seems inclined to do, could threaten its financial viability. Such a move also would suggest that the science is unsettled, that vaccines may be riskier than diseases, which is a fallacy.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Community health centers are key to delivering care in underserved communities around the country, but their services could be disrupted or scaled back after governments did not renew their funding.
As a warming climate intensifies storms, KFF Health News has identified more than 170 U.S. hospitals at risk of significant and potentially dangerous flooding. Climate experts warn that the Trump administration’s cuts leave the nation less prepared.
The health care sector has accounted for nearly half of this year’s U.S. job growth. But economists say immigration crackdowns and Medicaid cuts could create a drag on the sector just as more workers are needed to support a growing population of older Americans.
KFF Health News gives readers a chance to comment on a recent batch of stories.
Some injured patients say they wish they had tried harder to check the backgrounds of doctors and clinics they trusted, but those records are hard to find.
Under a new law, many Americans will have to meet a work requirement to obtain and keep their Medicaid coverage. But due to an exemption, millions living in areas of high unemployment could be spared.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.
© 2026 KFF